Results 91 to 100 of about 4,259,087 (330)

Rational Combinations Using HDAC Inhibitors [PDF]

open access: yesClinical Cancer Research, 2009
Abstract In addition to well-characterized genetic abnormalities that lead to cancer onset and progression, it is now recognized that alterations to the epigenome may also play a significant role in oncogenesis. As a result, epigenetic-modulating agents such as histone deacetylase inhibitors (HDACi) have attracted enormous attention as ...
Bots, Michael, Johnstone, Ricky W.
openaire   +2 more sources

In vitro profile of different HDAC inhibitors.

open access: yes, 2012
In vitro profile of different HDAC inhibitors.
Katherine T. Andrews (180935)   +5 more
core   +1 more source

ROS‐Responsive Nanoparticle Delivery of Dexmedetomidine Protects the Gut Vascular Barrier After Intestinal Ischemia/Reperfusion via the HDAC‐H3K27ac‐TCF4 Axis

open access: yesAdvanced Science, EarlyView.
A low dose of dexmedetomidine, delivered by ROS‐responsive nanoparticles, preferentially accumulates in the ischemic intestine and restores gut vascular barrier integrity after ischemia/reperfusion injury. This nanoparticle‐based strategy prevents bacterial translocation and liver damage without cardiorespiratory side effects, working through HDAC ...
Hu‐Fei Zhang   +10 more
wiley   +1 more source

HDAC Inhibitors: Therapeutic Potential in Fibrosis-Associated Human Diseases

open access: yesInternational Journal of Molecular Sciences, 2019
Fibrosis is characterized by excessive deposition of the extracellular matrix and develops because of fibroblast differentiation during the process of inflammation. Various cytokines stimulate resident fibroblasts, which differentiate into myofibroblasts.
Somy Yoon, Gaeun Kang, G. Eom
semanticscholar   +1 more source

Hydroxamate HDAC inhibitors potency in mediating dentine regeneration: a review

open access: yes
The quality of the reparative dentin structure is influenced by the signaling molecules contained in the pulp-capping material applied. A tunnel defect has been found in reparative dentin under treatment with conventional pulp-capping materials.
Ariyani, A P   +3 more
core   +1 more source

Doses of HDAC Inhibitors Used in Viral Replication Experiments.

open access: yes, 2014
Doses of HDAC Inhibitors Used in Viral Replication Experiments.
James J. Cody (342057)   +2 more
core   +1 more source

Matrix Rigidity Mechanoprimes Microglia for Inflammation Through Cytoskeletal‐to‐Nuclear Signaling and 3D Spatio‐Epigenomic Remodeling

open access: yesAdvanced Science, EarlyView.
Pathological tissue rigidity mechanoprimes microglia by enhancing actin cytoskeleton–nucleus coupling and chromatin opening at rigidity‐responsive cis‐regulatory elements (mechanoCREs). Subsequent NF‐κB/p65 signaling converges on this permissive regulatory state to amplify inflammatory gene expression and microglial activation.
Yu Xuan Meng   +15 more
wiley   +1 more source

Lactylation‐Driven PROS1‐TYRO3‐CARF Signaling Promotes Therapy‐Induced Senescence Escape and Radioresistance in Meningioma

open access: yesAdvanced Science, EarlyView.
A glycolysis‐driven epigenetic switch promotes therapy resistance in meningioma. Increased lactate production enhances histone H3K27 lactylation, which activates PROS1 secretion. Secreted PROS1 engages TYRO3 signaling to degrade the senescence regulator CARF, allowing cancer cells to escape growth arrest.
Zhuohang Wang   +12 more
wiley   +1 more source

Aspirin‐Derived Salicyl‐CoA Drives Histone Lysine Salicylation Regulated by CBP and SIRT2

open access: yesAdvanced Science, EarlyView.
Aspirin‐derived salicyl‐CoA serves as a previously unrecognized acyl donor for protein lysine salicylation. This study identifies histone lysine salicylation as a reversible epigenetic modification regulated by CBP and SIRT2, expanding the biochemical actions of aspirin beyond its canonical acetylation‐dependent mechanisms and providing a new framework
Facai Zhang   +15 more
wiley   +1 more source

Design, Synthesis, and In-silico Evaluation of Benzyl oxybenzoate Derivatives as Dual HDAC Inhibitors for Cancer and CNS Disorders

open access: yesAl-Mustansiriyah Journal of Pharmaceutical Sciences
Histone deacetylase (HDAC) inhibitors have garnered attention as possible therapies for disorders affecting the central nervous system (CNS) and cancer.
Dhiaa Ali Abdulkader   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy